Current Affairs World

Daily Current Affairs: 08-12-2025 | Prelim Booster

Topics for UPSC, SSC & All Competitive Exams - Currentaffairsworld.in

Current Affairs – 08-12-2025

1. India recently achieved a significant milestone with the successful hot-fire test of its new-generation ‘Agni-X’ semi-cryogenic engine. Which organization developed this engine?

A) ISRO

B) DRDO

C) HAL

D) BEL


2. The recently concluded COP30 summit in Manaus, Brazil, saw the establishment of a groundbreaking ‘Amazon Carbon Sink Preservation Fund’. Which of the following is a key objective of this fund?

A) To finance renewable energy projects in European nations.

B) To provide direct aid for industrial development in Asia.

C) To support indigenous communities and sustainable forestry in the Amazon basin.

D) To fund deep-sea mining exploration.


3. The Reserve Bank of India (RBI) recently announced the successful pilot completion of Phase 2 of the e-Rupee (Central Bank Digital Currency) for retail transactions, emphasizing greater interoperability. Which of the following is a primary feature introduced in this phase?

A) Direct linkage to international cryptocurrencies.

B) Offline transaction capabilities for remote areas.

C) Exclusion of small businesses from participation.

D) Requirement for all transactions to be above INR 10,000.


4. India recently finalized a landmark trilateral defence cooperation agreement, ‘Operation Trident’, with two key partners focusing on maritime security and anti-piracy operations in the Indo-Pacific. Which two countries are India’s partners in this new initiative?

A) Russia and China

B) United States and Japan

C) Australia and Indonesia

D) France and UAE


5. The Indian Council of Medical Research (ICMR) and a leading pharmaceutical company recently announced the successful Phase III trial results for ‘Vax Dengue’, India’s indigenous vaccine against Dengue fever. This vaccine is expected to significantly reduce disease burden. What is a key characteristic of the ‘Vax Dengue’ vaccine’s development?

A) It is based on an inactivated virus platform.

B) It targets only one serotype of the Dengue virus.

C) It offers protection against all four Dengue virus serotypes.

D) It requires only a single dose for lifelong immunity.


Stay Updated Every Morning with Daily Current Affairs 2025


Discover more from Current Affairs World

Subscribe to get the latest posts sent to your email.

You may also like these

Discover more from Current Affairs World

Subscribe now to keep reading and get access to the full archive.

Continue reading